Potential Immunotherapy, Bria-IMT, Seen to Reduce Metastasis in Advanced Breast Cancer Patients in Trial – Breast Cancer News
Breast Cancer News |
Potential Immunotherapy, Bria-IMT, Seen to Reduce Metastasis in Advanced Breast Cancer Patients in Trial
Breast Cancer News Bria-IMT, also called SV-BR-1-GM, is a potential immunotherapy made of a breast tumor cell line engineered to release a factor – called granulocyte-macrophage colony-stimulating factor (GM-CSF) – that activates the immune system with a goal of … |
